181 related articles for article (PubMed ID: 14741292)
1. Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: tertiary amides.
Chan L; Pereira O; Reddy TJ; Das SK; Poisson C; Courchesne M; Proulx M; Siddiqui A; Yannopoulos CG; Nguyen-Ba N; Roy C; Nasturica D; Moinet C; Bethell R; Hamel M; L'Heureux L; David M; Nicolas O; Courtemanche-Asselin P; Brunette S; Bilimoria D; Bédard J
Bioorg Med Chem Lett; 2004 Feb; 14(3):797-800. PubMed ID: 14741292
[TBL] [Abstract][Full Text] [Related]
2. Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: Sulfonamides.
Chan L; Das SK; Reddy TJ; Poisson C; Proulx M; Pereira O; Courchesne M; Roy C; Wang W; Siddiqui A; Yannopoulos CG; Nguyen-Ba N; Labrecque D; Bethell R; Hamel M; Courtemanche-Asselin P; L'Heureux L; David M; Nicolas O; Brunette S; Bilimoria D; Bédard J
Bioorg Med Chem Lett; 2004 Feb; 14(3):793-6. PubMed ID: 14741291
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of lactam-thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitors.
Barnes-Seeman D; Boiselle C; Capacci-Daniel C; Chopra R; Hoffmaster K; Jones CT; Kato M; Lin K; Ma S; Pan G; Shu L; Wang J; Whiteman L; Xu M; Zheng R; Fu J
Bioorg Med Chem Lett; 2014 Aug; 24(16):3979-85. PubMed ID: 24986660
[TBL] [Abstract][Full Text] [Related]
4. PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication.
Lam AM; Murakami E; Espiritu C; Steuer HM; Niu C; Keilman M; Bao H; Zennou V; Bourne N; Julander JG; Morrey JD; Smee DF; Frick DN; Heck JA; Wang P; Nagarathnam D; Ross BS; Sofia MJ; Otto MJ; Furman PA
Antimicrob Agents Chemother; 2010 Aug; 54(8):3187-96. PubMed ID: 20516278
[TBL] [Abstract][Full Text] [Related]
5. HCV NS5B polymerase-bound conformation of a soluble sulfonamide inhibitor by 2D transferred NOESY.
Yannopoulos CG; Xu P; Ni F; Chan L; Pereira OZ; Reddy TJ; Das SK; Poisson C; Nguyen-Ba N; Turcotte N; Proulx M; Halab L; Wang W; Bédard J; Morin N; Hamel M; Nicolas O; Bilimoria D; L'Heureux L; Bethell R; Dionne G
Bioorg Med Chem Lett; 2004 Nov; 14(21):5333-7. PubMed ID: 15454222
[TBL] [Abstract][Full Text] [Related]
6. Tetrahydrobenzothiophene inhibitors of hepatitis C virus NS5B polymerase.
Laporte MG; Lessen TA; Leister L; Cebzanov D; Amparo E; Faust C; Ortlip D; Bailey TR; Nitz TJ; Chunduru SK; Young DC; Burns CJ
Bioorg Med Chem Lett; 2006 Jan; 16(1):100-3. PubMed ID: 16260131
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.
McKercher G; Beaulieu PL; Lamarre D; LaPlante S; Lefebvre S; Pellerin C; Thauvette L; Kukolj G
Nucleic Acids Res; 2004; 32(2):422-31. PubMed ID: 14739234
[TBL] [Abstract][Full Text] [Related]
8. 2-(3-Thienyl)-5,6-dihydroxypyrimidine-4-carboxylic acids as inhibitors of HCV NS5B RdRp.
Pacini B; Avolio S; Ercolani C; Koch U; Migliaccio G; Narjes F; Pacini L; Tomei L; Harper S
Bioorg Med Chem Lett; 2009 Nov; 19(21):6245-9. PubMed ID: 19800789
[TBL] [Abstract][Full Text] [Related]
9. Cyclic amide bioisosterism: strategic application to the design and synthesis of HCV NS5B polymerase inhibitors.
Yang H; Hendricks RT; Arora N; Nitzan D; Yee C; Lucas MC; Yang Y; Fung A; Rajyaguru S; Harris SF; Leveque VJ; Hang JQ; Pogam SL; Reuter D; Tavares GA
Bioorg Med Chem Lett; 2010 Aug; 20(15):4614-9. PubMed ID: 20584604
[TBL] [Abstract][Full Text] [Related]
10. Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency.
Beaulieu PL; Bös M; Bousquet Y; DeRoy P; Fazal G; Gauthier J; Gillard J; Goulet S; McKercher G; Poupart MA; Valois S; Kukolj G
Bioorg Med Chem Lett; 2004 Feb; 14(4):967-71. PubMed ID: 15013003
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymerase.
Maynard A; Crosby RM; Ellis B; Hamatake R; Hong Z; Johns BA; Kahler KM; Koble C; Leivers A; Leivers MR; Mathis A; Peat AJ; Pouliot JJ; Roberts CD; Samano V; Schmidt RM; Smith GK; Spaltenstein A; Stewart EL; Thommes P; Turner EM; Voitenleitner C; Walker JT; Waitt G; Weatherhead J; Weaver K; Williams S; Wright L; Xiong ZZ; Haigh D; Shotwell JB
J Med Chem; 2014 Mar; 57(5):1902-13. PubMed ID: 23672667
[TBL] [Abstract][Full Text] [Related]
12. Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: from benzimidazole to indole scaffolds.
Beaulieu PL; Gillard J; Bykowski D; Brochu C; Dansereau N; Duceppe JS; Haché B; Jakalian A; Lagacé L; LaPlante S; McKercher G; Moreau E; Perreault S; Stammers T; Thauvette L; Warrington J; Kukolj G
Bioorg Med Chem Lett; 2006 Oct; 16(19):4987-93. PubMed ID: 16908138
[TBL] [Abstract][Full Text] [Related]
13. Tri-substituted acylhydrazines as tertiary amide bioisosteres: HCV NS5B polymerase inhibitors.
Canales E; Carlson JS; Appleby T; Fenaux M; Lee J; Tian Y; Tirunagari N; Wong M; Watkins WJ
Bioorg Med Chem Lett; 2012 Jul; 22(13):4288-92. PubMed ID: 22664130
[TBL] [Abstract][Full Text] [Related]
14. Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase.
Reddy TJ; Chan L; Turcotte N; Proulx M; Pereira OZ; Das SK; Siddiqui A; Wang W; Poisson C; Yannopoulos CG; Bilimoria D; L'Heureux L; Alaoui HM; Nguyen-Ba N
Bioorg Med Chem Lett; 2003 Oct; 13(19):3341-4. PubMed ID: 12951122
[TBL] [Abstract][Full Text] [Related]
15. Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cells.
Beaulieu PL; Bousquet Y; Gauthier J; Gillard J; Marquis M; McKercher G; Pellerin C; Valois S; Kukolj G
J Med Chem; 2004 Dec; 47(27):6884-92. PubMed ID: 15615537
[TBL] [Abstract][Full Text] [Related]
16. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.
Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K
Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671
[TBL] [Abstract][Full Text] [Related]
17. Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus.
Le Pogam S; Kang H; Harris SF; Leveque V; Giannetti AM; Ali S; Jiang WR; Rajyaguru S; Tavares G; Oshiro C; Hendricks T; Klumpp K; Symons J; Browner MF; Cammack N; Nájera I
J Virol; 2006 Jun; 80(12):6146-54. PubMed ID: 16731953
[TBL] [Abstract][Full Text] [Related]
18. Mutations in NS5B polymerase of hepatitis C virus: impacts on in vitro enzymatic activity and viral RNA replication in the subgenomic replicon cell culture.
Cheney IW; Naim S; Lai VC; Dempsey S; Bellows D; Walker MP; Shim JH; Horscroft N; Hong Z; Zhong W
Virology; 2002 Jun; 297(2):298-306. PubMed ID: 12083828
[TBL] [Abstract][Full Text] [Related]
19. Benzimidazole inhibitors of hepatitis C virus NS5B polymerase: identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole.
Ishida T; Suzuki T; Hirashima S; Mizutani K; Yoshida A; Ando I; Ikeda S; Adachi T; Hashimoto H
Bioorg Med Chem Lett; 2006 Apr; 16(7):1859-63. PubMed ID: 16455252
[TBL] [Abstract][Full Text] [Related]
20. Active site inhibitors of HCV NS5B polymerase. The development and pharmacophore of 2-thienyl-5,6-dihydroxypyrimidine-4-carboxylic acid.
Stansfield I; Avolio S; Colarusso S; Gennari N; Narjes F; Pacini B; Ponzi S; Harper S
Bioorg Med Chem Lett; 2004 Oct; 14(20):5085-8. PubMed ID: 15380204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]